V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230000570 | 230001174 | 1.82 | 92.9 | Adjuvant (A) | 2017-01-09 | 2018-02-22 | Oxaliplatin + Modified de Gramont | N | N | 230006255 | CARBOPLATIN + PACLITAXEL |
| 230000571 | 230001174 | 1.68 | 60.1 | Adjuvant (A) | 2016-02-08 | 2016-02-18 | FLUOROURACIL | N | N | 230006255 | CVP R |
| 230000572 | 230000335 | 1.58 | 43 | Adjuvant (A) | 2017-09-17 | 2017-10-01 | Capecitabine | N | N | 230006366 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 230000573 | 230000335 | 1.59 | 61 | Palliative (P) | 2016-05-11 | 2016-06-01 | VANDETANIB | null | null | 230006366 | IRINOTECAN + MDG |
| 230000574 | 230000336 | 1.7 | null | Adjuvant (A) | 2017-06-26 | 2017-06-26 | Bevacizumab + Cape + Oxali 21day | N | N | 230006394 | GEMCITABINE |
| 230000575 | 230001176 | null | 60.7 | Disease modification (D) | 2015-11-17 | 2015-11-17 | Cisplatin + Pemetrexed | 02 | N | 230006431 | CAPECITABINE + CARBOPLATIN |
| 230000576 | 230001176 | 1.83 | 84.7 | Palliative (P) | 2015-07-14 | 2015-07-14 | Bevacizumab 5mg/kg | 02 | N | 230006431 | CAPECITABINE + RT |
| 230000577 | 230001176 | 1.73 | 122.6 | null | 2015-06-11 | 2015-06-11 | CAPECITABINE + OXALIPLATIN | N | N | 230006431 | EOX |
| 230000578 | 230000337 | 1.74 | 84.1 | Palliative (P) | 2013-06-30 | 2013-06-30 | Capecitabine + Oxaliplatin 14day | 02 | N | 230006505 | PEG INTERFERON |
| 230000579 | 230000337 | null | 58.6 | Adjuvant (A) | 2018-01-13 | 2018-01-19 | FLUOROURACIL + MITOMYCIN + RT | 02 | N | 230006505 | CAPECITABINE + OXALIPLATIN |
| 230000580 | 230000337 | 1.83 | 80.9 | Palliative (P) | 2014-12-21 | 2014-12-22 | Pazopanib | 02 | N | 230006505 | CHOP R |
| 230000581 | 230000338 | 1.71 | 77.3 | Curative (C) | 2017-02-15 | 2017-02-28 | SCOT TRIAL | 02 | Y | 230006575 | CHOP R |
| 230000582 | 230000339 | 1.75 | 70.9 | Palliative (P) | 2016-03-24 | 2016-04-20 | Capecitabine + Oxaliplatin 21day | 02 | N | 230006606 | SORAFENIB |
| 230000583 | 230001178 | 1.68 | 89.4 | null | 2017-11-12 | 2017-11-26 | VANDETANIB | 02 | null | 230006654 | OXALIPLATIN + MDG |
| 230000584 | 230000340 | null | 90.3 | Adjuvant (A) | 2014-10-29 | 2014-10-29 | FLUOROURACIL + MITOMYCIN | 2 | null | 230006718 | GEMCARBO |
| 230000585 | 230001179 | 0.01 | 51.3 | Neo-adjuvant (N) | 2017-01-01 | 2017-02-17 | Capecitabine 35days + RT | N | Y | 230006781 | CAPECITABINE + OXALIPLATIN |
| 230000586 | 230000341 | 1.55 | 72.5 | Adjuvant (A) | 2017-03-08 | 2017-03-17 | CISPLATIN + RT | null | N | 230006821 | CAPECITABINE + OXALIPLATIN |
| 230000587 | 230000341 | 1.7 | 69.799 | Palliative (P) | 2017-04-11 | 2017-04-27 | Gemcitabine weekly | N | null | 230006821 | CAPECITABINE + OXALIPLATIN |
| 230000588 | 230000342 | 1.83 | 84 | Disease modification (D) | 2013-10-08 | 2013-10-28 | Irinotecan + Modified De Gramont | N | N | 230006832 | FLUOROURACIL |
| 230000589 | 230000342 | null | 70.8 | Adjuvant (A) | 2015-03-30 | 2015-03-30 | FLUOROURACIL + MITOMYCIN + RT | N | N | 230006832 | CAPECITABINE + OXALIPLATIN |
| 230000590 | 230000342 | 1.61 | 65.4 | Adjuvant (A) | 2014-09-07 | 2014-09-10 | SCOT TRIAL | N | Y | 230006832 | VANDETANIB |
| 230000591 | 230000343 | 1.71 | 95 | Palliative (P) | 2016-06-23 | 2016-06-23 | CARBOPLATIN + RT | N | N | 230006908 | TEMOZOLOMIDE |
| 230000592 | 230001182 | 1.87 | 71 | Palliative (P) | 2017-02-07 | 2017-02-18 | Capecitabine + Oxaliplatin 21day | 2 | N | 230007002 | CAPECITABINE |
| 230000593 | 230001509 | 1.61 | 66.5 | Adjuvant (A) | 2017-09-17 | 2017-10-01 | Cisplatin + Radiotherapy + CISPLATIN | N | N | 230007010 | FEC + DOCETAXEL |
| 230000594 | 230001509 | null | 61.5 | Palliative (P) | 2018-06-13 | 2018-06-20 | CAP + RT | N | N | 230007010 | CAPECITABINE |
| 230000595 | 230000344 | null | null | null | 2016-09-24 | 2016-09-25 | CAPECITABINE + RT | N | N | 230007086 | CAPECITABINE |
| 230000596 | 230000345 | 1.84 | 78.7 | Curative (C) | 2013-06-26 | 2013-06-28 | Capecitabine | 02 | Y | 230007089 | CARBOPLATIN + ETOPOSIDE |
| 230000597 | 230000346 | 1.88 | 60.3 | null | 2015-10-11 | 2015-10-14 | Cisplatin + Etoposide po&iv 3 day | 02 | N | 230007118 | CAPECITABINE |
| 230000598 | 230001183 | 1.6 | 73.3 | Curative (C) | 2014-08-19 | 2014-09-15 | Capecitabine + Oxaliplatin 21day | N | Y | 230007151 | CHLORAMBUCIL + OBINUTUZUMAB |
| 230000599 | 230000347 | 1.68 | 64.5 | Curative (C) | 2015-04-19 | 2015-04-22 | Cisplatin + Doxorubicin | 2 | Y | 230007202 | CAPECITABINE + GEMCITABINE |
| 230000600 | 230000348 | 1.66 | 72.5 | Palliative (P) | 2014-06-13 | 2014-06-25 | Cisplatin + Radiotherapy | 02 | N | 230007216 | CAPECITABINE + CISPLATIN + EPIRUBICIN |
| 230000601 | 230000349 | 1.68 | 66.5 | Adjuvant (A) | 2014-05-15 | 2014-05-23 | Fluorouracil + Folinic Acid Weekly | N | N | 230007239 | CISPLATIN + RT |
| 230000602 | 230000350 | 1.72 | 101.2 | Curative (C) | 2017-05-19 | 2017-05-27 | Fluorouricil + Folonic Acid (MdG) | N | N | 230007269 | OXALIPLATIN + MDG |
| 230000603 | 230000351 | 1.57 | 70.8 | null | 2014-11-04 | 2014-11-25 | FLUOROURACIL + MITOMYCIN | N | N | 230007304 | OXALIPLATIN + MDG |
| 230000604 | 230001184 | 1.78 | 59 | Neo-adjuvant (N) | 2015-06-05 | 2015-07-02 | Cisplatin + Radiotherapy | N | Y | 230007314 | CARBOPLATIN + PACLITAXEL |
| 230000605 | 230000352 | 1.75 | 73.6 | Adjuvant (A) | 2014-10-21 | 2014-10-30 | IMATINIB | 2 | N | 230007340 | CISPLATIN + RT |
| 230000606 | 230000353 | 1.87 | 79.4 | Palliative (P) | 2015-08-05 | 2015-08-14 | Capecitabine + Oxaliplatin 14day | N | N | 230007381 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 230000607 | 230000354 | 1.65 | null | Curative (C) | 2016-04-03 | 2016-04-15 | CISPLATIN + FLUOROURACIL | N | Y | 230007391 | FLUOROURACIL |
| 230000608 | 230000355 | 1.62 | 64.5 | Neo-adjuvant (N) | 2014-10-11 | 2014-10-24 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | N | 230007405 | CTD |
| 230000609 | 230000356 | 1.86 | 70.3 | Curative (C) | 2014-10-04 | 2014-10-12 | Fluorouracil + Folinic Acid Weekly | 2 | N | 230007425 | CAPECITABINE |
| 230000610 | 230000356 | 1.63 | 134 | Curative (C) | 2015-10-31 | 2015-11-11 | EC | 2 | N | 230007425 | DOXORUBICIN |
| 230000611 | 230000357 | 1.83 | 70 | Curative (C) | 2013-05-01 | 2013-05-26 | Docetaxel 75mg/m2 (21 day) | N | N | 230007459 | TEMOZOLOMIDE |
| 230000612 | 230000358 | 1.68 | 58 | Neo-adjuvant (N) | 2017-12-11 | 2017-12-21 | Carboplatin + Paclitaxel (3 weekly) | N | Y | 230007468 | IRINOTECAN + MDG |
| 230000613 | 230000358 | null | null | Palliative (P) | 2013-11-23 | 2013-12-08 | Paclitaxel 7 day | N | null | 230007468 | CISPLATIN + DOXORUBICIN |
| 230000614 | 230000358 | 1.63 | 56.8 | Adjuvant (A) | 2016-10-28 | 2016-10-28 | Cisplatin + Doxorubicin | 2 | N | 230007468 | CARBOPLATIN + PACLITAXEL |
| 230000615 | 230000359 | -1 | null | null | null | 2016-04-12 | CABOZANTINIB | N | N | 230007490 | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE |
| 230000616 | 230000359 | 1.81 | 82.6 | Palliative (P) | 2017-09-18 | 2017-09-19 | Capecitabine + Oxaliplatin 21day | 02 | N | 230007490 | CAPECITABINE + MITOMYCIN |
| 230000617 | 230000359 | 1.6 | 76.2 | Adjuvant (A) | 2017-05-02 | 2017-05-14 | Oxaliplatin + Modified de Gramont | N | N | 230007490 | SORAFENIB |
| 230000618 | 230000360 | null | 42.2 | Neo-adjuvant (N) | null | 2013-11-13 | Cisplatin + Doxorubicin | N | Y | 230007563 | CARBOPLATIN + ETOPOSIDE |
| 230000619 | 230001188 | 1.6 | 78.2 | Neo-adjuvant (N) | 2013-10-23 | 2013-11-10 | Capecitabine | N | N | 230007589 | SORAFENIB |